CompoAtlas

Allergollya

Food supplement declared in France, declaration No 2020-7-550, decision dated 10 July 2020

Allergollya is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
OM QUANTALLYA
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
6 gélules
Directions for use
entretien 2 à 3 gélules par jour / attaque :3 à 6 gélules par jour
Not recommended for (according to the manufacturer)
Femmes enceintes

Declaration 303904, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Plantago lanceolata L.FeuilleExtrait sec aqueux780 mg
Perilla frutescens (L.) BrittonGraine (huile)Extrait sec aqueux660 mg
Ribes nigrum L.FeuilleExtrait sec aqueux480 mg
Silybum marianum (L.) Gaertn.FruitExtrait sec aqueux240 mg

Additives

E470b

Other ingredients

Gélule végétale

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2020. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2020. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line